Key facts
- Notable investors include IDG Capital, EdiGene, Shenzhen Jiadaogu Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Yidong Ruicheng
- ·The full record, as it builds
Funding rounds
No funding rounds for Yidong Ruicheng are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yidong Ruicheng
Developer of a biotechnology platform designed to advance healthcare through innovative medical research and development. The company offers cutting-edge research capabilities, advanced laboratory infrastructure, and clinical trial expertise, enabling healthcare providers and patients to access more efficient, safer, and scientifically driven medical interventions.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Yidong Ruicheng doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yidong Ruicheng shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yidong Ruicheng in its N-PORT filings yet. We sweep new filings monthly.